News Related to Lixte

Related coverage linked through entity extraction aliases.

LIXTE Biotechnology Appoints Sidney Braun as CEO of Liora Technologies Subsidiary

Mar 11, 2026

LIXTE Biotechnology Holdings appointed Sidney Braun as CEO of its Liora Technologies Europe Ltd. subsidiary to lead advancement of the LiGHT System proton therapy platform following the company's November 2025 acquisition of Liora's assets.

LIXTE Biotechnology Advances PP2A Inhibitor to Enhance Cancer Therapies

Feb 13, 2026

LIXTE Biotechnology Holdings is developing LB-100, a first-in-class PP2A inhibitor designed to enhance chemotherapy and immunotherapy effectiveness across multiple cancer types, with proof-of-concept trials underway.